Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Gabapentin to Treat Itch in Patients With Liver Disease
This study has been completed.
Study NCT00058890 Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: April 14, 2003 Last Updated: December 1, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Liver Disease
Cholestasis
Cirrhosis
Pruritus
Itching
Additional conditions recognized in this trial
Fibrosis
Liver Cirrhosis
Liver Diseases
More general conditions related to this trial
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Pathologic Processes
Signs and Symptoms
Skin Diseases
Skin Manifestations
Interventions listed in this trial
gabapentin
More general drug interventions related to this trial
Analgesics
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antimanic Agents
Antiparkinson Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Back to top of Main Content
